Accelerating Clinical Development In Japan And China: Pricing, Inspection And Regulatory Trends

The Asia-Pacific (APAC) clinical trials market reached approximately US $3.8 billion in 2019, and is projected to grow to around US$5.2 billion by the end of 2024, with the highest CAGR in the world.

The APAC market has a large treatment naïve population, and has shown improvements in the regulatory environment which could help in faster clinical development. However, many pharma companies face challenges in strategy development due to local specific regulatory processes and a lack of local resources.

In this webinar, industry experts at CMIC Group will present insights and tips for successful clinical development in the APAC region, which will include:

• APAC market overview
• Regulatory and operational environment in APAC
• Key hurdles and success factors for clinical trials in APAC
• Case study: How to hold successful clinical trials in Japan and other key APAC countries